BioSyent Releases Q2 and Six Month Results: Six Month Sales Increase 57% and Profit Before Tax Up 68%

TORONTO, ONTARIO -- (Marketwired) -- 08/22/13 -- BioSyent Inc. ("BioSyent") (TSX VENTURE: RX) released today a summary of its second quarter (Q2) and first half (H1) 2013 financial results for the three and six months ending June 30, 2013.Total sales for Q2 2013 of $1,786,685, were 47% h ...